Clinical Trial Update: A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of trastuzumab deruxtecan (Enhertu) in previously treated advanced or metastatic HER2-positive breast cancer, including participants with brain me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-16